No new institutional positions this quarter.
Brainstorm Cell Therapeutics Inc. OQB:BCLI
Institutional holders, quarter-over-quarter share deltas, and new and closed positions disclosed in Form 13F. Period 2025-03-31 · prior 2024-12-31.
Added To(1)
| Manager | Shares | Δ Shares | Value | Δ Value | % Δ |
|---|---|---|---|---|---|
| MORGAN STANLEY | 86,438 | +36,975 | $23.9K | +$12.5K | 74.8% |
Sold Out(5)
| Manager | Shares | Δ Shares | Value | Δ Value | % Δ |
|---|---|---|---|---|---|
| LIBERTY WEALTH MANAGEMENT LLC | 0 | -22,666 | $0 | -$51.5K | — |
| Weaver Consulting Group | 0 | -15,623 | $0 | -$35.5K | — |
| ADVISOR GROUP HOLDINGS, INC. | 0 | -10,519 | $0 | -$2.4K | — |
| VSM Wealth Advisory, LLC | 0 | -120 | $0 | -$272 | — |
| JPMORGAN CHASE & CO | 0 | -607 | $0 | -$205 | — |
Top Holders by reported value
Ranked by the dollar value reported on the latest Form 13F. Share counts reflect long positions as of 2025-03-31.
| Manager | Shares | $ Value | Δ Shares | QoQ % |
|---|---|---|---|---|
| MORGAN STANLEY | 86,438 | $23.9K | +36,975 | 74.8% |
New & Closed Positions this quarter
Methodology
Form 13F is the SEC's quarterly disclosure for institutional investment managers exercising discretion over $100 million or more in qualifying U.S. equity securities. Managers must file within 45 days of each calendar quarter end, which is why holdings shown here reflect a snapshot at the period date — not real-time positioning.
Quarter-over-quarter deltas compare each manager's most recently reported share count for BCLI against its prior-quarter count. New positions are entries where the prior count was zero; closed positions are entries where the current count is zero. Amendments (13F-HR/A) replace prior filings for the same period.
Source: SEC EDGAR Form 13F (XML information tables). Dollar values are as reported by the manager and may use mid-quarter pricing conventions. CUSIP-to-ticker resolution is best-effort.